Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
<i>Bifidobacterium infantis</i> Potentially Alleviates Shrimp Tropomyosin-Induced Allergy by Tolerogenic Dendritic Cell-Dependent Induction of Regulatory T Cells and Alterations in Gut Microbiota. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 8 Issue Pages: 1536 Pub: 2017 Epub: 2017 Nov 10 Authors Fu L , Song J , Wang C , Fu S , Wang Y , |
|
|
The effect of synbiotics Bifidobacterium infantis and milk oligosaccharides on shaping gut microbiota community structure and NASH treatment. ✅
Go to Publication ✅
Data in brief (Data Brief ) Vol: 19 Issue Pages: 1025-1029 Pub: 2018 Aug Epub: 2018 May 24 Authors Jena PK , Sheng L , Nagar N , Wu C , Barile D , Mills DA , Wan YY , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
|
|
Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice. ✅
Go to Publication ✅
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (Biomed Pharmacother ) Vol: 182 Issue Pages: 117749 Pub: 2025 Jan Epub: 2024 Dec 23 Authors Funayama E , Hosonuma M , Tajima K , Isobe J , Baba Y , Murayama M , Narikawa Y , Toyoda H , Tsurui T , Maruyama Y , Sasaki A , Amari Y , Yamazaki Y , Nakashima R , Uchiyama J , Nakano R , Shida M , Sasaki A , Udaka Y , Oguchi T , Sambe T , Kobayashi S , Tsuji M , Kiuchi Y , Kim YG , Wada S , Tsunoda T , Akiyama M , Nobe K , Kuramasu A , Yoshimura K , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
